Robert Kleiman

1.2k total citations
37 papers, 759 citations indexed

About

Robert Kleiman is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robert Kleiman has authored 37 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 10 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robert Kleiman's work include Cardiac electrophysiology and arrhythmias (32 papers), Cardiac pacing and defibrillation studies (13 papers) and Cardiac Arrhythmias and Treatments (8 papers). Robert Kleiman is often cited by papers focused on Cardiac electrophysiology and arrhythmias (32 papers), Cardiac pacing and defibrillation studies (13 papers) and Cardiac Arrhythmias and Treatments (8 papers). Robert Kleiman collaborates with scholars based in United States, Canada and Switzerland. Robert Kleiman's co-authors include Steven R. Houser, Francis E. Marchlinski, David J. Callans, Bruce G. Hook, Belinda Flores, Joel Morganroth, Henrik Hartmann, D.J. Albert, Raman Mitra and J. Martijn Bos and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Robert Kleiman

35 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Kleiman United States 15 629 245 106 47 36 37 759
Jürg Schläpfer Switzerland 14 772 1.2× 241 1.0× 57 0.5× 76 1.6× 45 1.3× 37 954
Y. G. Yap United Kingdom 7 685 1.1× 363 1.5× 63 0.6× 56 1.2× 13 0.4× 11 914
Lance D. Wilson United States 17 624 1.0× 388 1.6× 131 1.2× 48 1.0× 41 1.1× 41 936
Shinichi Niwano Japan 21 1.4k 2.3× 226 0.9× 61 0.6× 85 1.8× 42 1.2× 157 1.6k
Gerardo Nau Argentina 16 1.1k 1.7× 191 0.8× 42 0.4× 193 4.1× 69 1.9× 40 1.3k
Jurren M. van Opstal Netherlands 13 1.2k 1.9× 587 2.4× 91 0.9× 34 0.7× 29 0.8× 38 1.2k
Heinz F. Pitschner Germany 20 1.4k 2.3× 105 0.4× 55 0.5× 121 2.6× 63 1.8× 65 1.6k
Jet D.M. Beekman Netherlands 20 1.4k 2.3× 892 3.6× 128 1.2× 27 0.6× 25 0.7× 42 1.5k
Larry S. Green United States 13 772 1.2× 324 1.3× 56 0.5× 33 0.7× 91 2.5× 20 867
Gerrit Frommeyer Germany 25 1.8k 2.9× 536 2.2× 117 1.1× 152 3.2× 88 2.4× 194 2.1k

Countries citing papers authored by Robert Kleiman

Since Specialization
Citations

This map shows the geographic impact of Robert Kleiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Kleiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Kleiman more than expected).

Fields of papers citing papers by Robert Kleiman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Kleiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Kleiman. The network helps show where Robert Kleiman may publish in the future.

Co-authorship network of co-authors of Robert Kleiman

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Kleiman. A scholar is included among the top collaborators of Robert Kleiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Kleiman. Robert Kleiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Libo, Fei Huang, Robert Kleiman, et al.. (2025). Low Proarrhythmic Risk of Imetelstat, a Novel Oligonucleotide Telomerase Inhibitor: A Translational Analysis. Clinical and Translational Science. 18(2). e70169–e70169.
2.
Chaudhary, Khuram W., Colleen E. Clancy, Pei‐Chi Yang, et al.. (2024). An overview of drug‐induced sodium channel blockade and changes in cardiac conduction: Implications for drug safety. Clinical and Translational Science. 17(12). e70098–e70098. 5 indexed citations
3.
Krantz, Mori J., Mark C. Haigney, Norman Stockbridge, et al.. (2023). Ventricular Arrhythmias Associated With Over-the-Counter and Recreational Opioids. Journal of the American College of Cardiology. 81(23). 2258–2268. 10 indexed citations
4.
Rossman, Eric I., Todd Wisialowski, Hugo M. Vargas, et al.. (2023). Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As. Journal of Pharmacological and Toxicological Methods. 123. 107270–107270. 12 indexed citations
5.
Kleiman, Robert, et al.. (2022). False Negative ECG Device Results May Increase the Risk of Adverse Events in Clinical Oncology Trials. Therapeutic Innovation & Regulatory Science. 56(4). 667–676. 2 indexed citations
6.
Giudicessi, John R., J. Martijn Bos, Conner Galloway, et al.. (2021). Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device. Circulation. 143(13). 1274–1286. 74 indexed citations
7.
Liranso, Tesfaye, et al.. (2020). Evaluation of the Effect of SPN-812 (Viloxazine Extended-Release) on QTc Interval in Healthy Adults. The Journal of Clinical Psychiatry. 81(6). 14 indexed citations
8.
Valade, Elodie, Anne‐Gaëlle Dosne, Hong Xie, et al.. (2019). Assessment of the effect of erdafitinib on cardiac safety: analysis of ECGs and exposure–QTc in patients with advanced or refractory solid tumors. Cancer Chemotherapy and Pharmacology. 84(3). 621–633. 7 indexed citations
9.
Idriss, Salim F., Stuart Berger, Kimberly G. Harmon, et al.. (2017). Prevention of sudden cardiac death in the young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium. American Heart Journal. 190. 123–131. 6 indexed citations
10.
Piccini, Jonathan P., Richard L. Clark, Peter R. Kowey, et al.. (2017). Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium. American Heart Journal. 187. 156–169. 6 indexed citations
11.
Avisar, Noa, et al.. (2015). A thorough QT study to assess the effects of tbo-filgrastim on cardiac repolarization in healthy subjects. Drug Design Development and Therapy. 9. 2653–2653. 1 indexed citations
12.
Kleiman, Robert, et al.. (2015). Benefits of Centralized ECG Reading in Clinical Oncology Studies. Therapeutic Innovation & Regulatory Science. 50(1). 123–129. 3 indexed citations
13.
Nada, Adel, Gary A. Gintant, Robert Kleiman, et al.. (2013). The evaluation and management of drug effects on cardiac conduction (PR and QRS Intervals) in clinical development. American Heart Journal. 165(4). 489–500. 43 indexed citations
14.
Min, Sherene, J. Rick Turner, Adel Nada, et al.. (2010). Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development. American Heart Journal. 159(5). 716–729. 16 indexed citations
15.
Gussak, Ihor, et al.. (2004). Drug-induced cardiac toxicity: emphasizing the role of electrocardiography in clinical research and drug development. Journal of Electrocardiology. 37(1). 19–24. 18 indexed citations
16.
Hsia, Henry H., Robert Kleiman, Belinda Flores, & Francis E. Marchlinski. (1994). Comparison of Simultaneous Versus Sequential Defibrillation Pulsing Techniques Using a Nonthoracotomy System. Pacing and Clinical Electrophysiology. 17(7). 1222–1230. 7 indexed citations
17.
Kleiman, Robert, David J. Callans, Bruce G. Hook, & Francis E. Marchlinski. (1994). Effectiveness of Noninvasive Programmed Stimulation for Initiating Ventricular Tachyarrhythmias in Patients with Third‐Generation Implantable Cardioverter Definrillators. Pacing and Clinical Electrophysiology. 17(9). 1462–1468. 15 indexed citations
18.
Callans, David J., Bruce G. Hook, Robert Kleiman, et al.. (1993). Unique sensing errors in third-generation implantable cardioverter-defibrillators. Journal of the American College of Cardiology. 22(4). 1135–1140. 47 indexed citations
19.
Buxton, Alfred E., Robert Kleiman, K. Elizabeth Kindwall, & Mark E. Josephson. (1993). Endocardial mapping during sinus rhythm in patients with coronary artery disease and nonsustained ventricular tachycardia. The American Journal of Cardiology. 71(8). 695–698. 11 indexed citations
20.
Kleiman, Robert, John M. Miller, Alfred E. Buxton, Mark E. Josephson, & Francis E. Marchlinski. (1988). Prognosis following sustained ventricular tachycardia occurring early after myocardial infarction. The American Journal of Cardiology. 62(9). 528–533. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026